Medicus Sciences Acquisition Corp.

Medicus Sciences Acquisition Corp. (Nasdaq: MSAC) was a blank-check company focused on the healthcare and life sciences sector, sponsored by Medicus Sciences LLC. The vehicle completed its IPO in 2021, targeting acquisition opportunities across therapeutics, medical technology, and related life sciences industries. On February 27, 2023, MSAC filed a Form 15-12G with the SEC, formally terminating its registration under Section 12(g) of the Securities Exchange Act of 1934, signaling the conclusion of its reporting obligations and the wind-down of the entity without a completed business combination. Visit SpacDesk and sign up for full data, filings, and analytics on MSAC and hundreds of other SPAC vehicles.